News
Abstract submission: Next-generation sequencing for venomics
ADDovenom researchers Fernanda Gobbi Amorim, Damien Redureau, Nicholas Casewell and Loïc Quinton have co-authored the following abstract, which has been submitted for the Venoms and
ADDovenom / BBI webinar with Prof Gérard Lambeau
On 5 May 2021, ADDovenom teamed up with colleagues at the Bristol BioDesign Institute to organise a webinar with Professor Gérard Lambeau from CNRS (Centre
27th Meeting of the French Society of Toxinology to be organised by Loïc Quinton
The French Society of Toxinology (SFET) is preparing for its 27th Meeting on Toxinology, entitled “Toxins: Mr Hyde or Dr Jekyll?”, on Thursday 9th and
IMI-EU funding to accelerate Advanced Therapy Medicinal Products
iBET participates in ARDAT – Accelerating Research and Innovation for Advanced Therapies – a project which aims to standardize and accelerate the development of Advanced Therapy Medicinal
Paula Alves elected for US National Academy of Engineering
Congratulations to ADDovenom project partner Paula Alves (CEO of iBET – Instituto de Biologia Experimental e Tecnológica), who has been elected foreign member of the
French newspaper ‘La Provence’ writes about ADDovenom
La Provence, the most read newspaper in the south of France, devoted a page of its 7 January 2021 edition the ADDovenom project. The article
Loïc Quinton secures F.R.S – FNRS funding for new ‘Venoms4Liège’ project
Congratulations to ADDovenom team member Loïc Quinton (University of Liège), who has been awarded four years of funding by F.R.S – FNRS for the project: “Venoms4Liège:
ADDovenom: an innovative treatment to reduce deaths due to snake bites
A new European project, led by the University of Bristol and involving the Mass Spectrometry Laboratory (MolSys Research Unit / Faculty of Sciences) of the ULiège, will develop a
Prof Rob Harrison on ‘LSTM’s research activity and impacts on tropical snakebite’
The former head of LSTM‘s Centre for Snakebite Research & Interventions (CSRI), Professor Rob Harrison, on behalf of Professors David Theakston, David Lalloo and Nick Casewell,
New type of antivenom to reduce 100,000 fatalities each year from venomous snake bites being developed by Bristol scientists
A new approach of treating life-threatening snake bites responsible for around 100,000 deaths globally each year is being pioneered by an international research consortium led
Latest Tweets
